Omnicell Inc (OMCL) is a publicly traded Healthcare sector company. As of August 31, 2026, OMCL trades at $35.16 with a market cap of $1.51B and a P/E ratio of 40.75. OMCL moved +6.35% today. Year to date, OMCL is -22.38%; over the trailing twelve months it is +7.89%. Its 52-week range spans $22.66 to $55.00. Analyst consensus is strong buy with an average price target of $55.00. Rallies surfaces OMCL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest OMCL news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $35.16 |
| Market Cap | $1.51B |
| P/E Ratio | 40.75 |
| EPS | $0.85 |
| Dividend Yield | 0.00% |
| 52-Week High | $55.00 |
| 52-Week Low | $22.66 |
| Volume | 724.48K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.25B |
| Net Income | $39.08M |
| Gross Margin | 44.77% |
6 analysts cover OMCL: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $55.00.